- Home
- VUZI vs GOSS Comparison
VUZI vs GOSS Comparison
Compare VUZI & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VUZI
- GOSS
- Stock Information
- Founded
- VUZI 1997
- GOSS 2015
- Country
- VUZI United States
- GOSS United States
- Employees
- VUZI N/A
- GOSS N/A
- Industry
- VUZI Industrial Machinery/Components
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- VUZI Technology
- GOSS Health Care
- Exchange
- VUZI Nasdaq
- GOSS Nasdaq
- Market Cap
- VUZI 236.4M
- GOSS 262.5M
- IPO Year
- VUZI N/A
- GOSS 2019
- Fundamental
- Price
- VUZI $2.76
- GOSS $1.25
- Analyst Decision
- VUZI Strong Buy
- GOSS Strong Buy
- Analyst Count
- VUZI 1
- GOSS 3
- Target Price
- VUZI $2.00
- GOSS $7.33
- AVG Volume (30 Days)
- VUZI 2.0M
- GOSS 2.6M
- Earning Date
- VUZI 08-13-2025
- GOSS 08-11-2025
- Dividend Yield
- VUZI N/A
- GOSS N/A
- EPS Growth
- VUZI N/A
- GOSS N/A
- EPS
- VUZI N/A
- GOSS N/A
- Revenue
- VUZI $5,331,630.00
- GOSS $124,590,000.00
- Revenue This Year
- VUZI $45.35
- GOSS N/A
- Revenue Next Year
- VUZI $54.01
- GOSS $91.14
- P/E Ratio
- VUZI N/A
- GOSS N/A
- Revenue Growth
- VUZI N/A
- GOSS N/A
- 52 Week Low
- VUZI $0.83
- GOSS $0.66
- 52 Week High
- VUZI $5.79
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- VUZI 51.22
- GOSS 49.48
- Support Level
- VUZI $2.67
- GOSS $1.20
- Resistance Level
- VUZI $2.92
- GOSS $1.33
- Average True Range (ATR)
- VUZI 0.19
- GOSS 0.10
- MACD
- VUZI -0.04
- GOSS -0.02
- Stochastic Oscillator
- VUZI 29.84
- GOSS 18.37
About VUZI Vuzix Corporation
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.